Logo image of J5A.DE

WARNER BROS DISCOVERY INC (J5A.DE) Stock Fundamental Analysis

FRA:J5A - Deutsche Boerse Ag - US9344231041 - Common Stock - Currency: EUR

7.572  -0.05 (-0.72%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to J5A. J5A was compared to 43 industry peers in the Entertainment industry. J5A has a bad profitability rating. Also its financial health evaluation is rather negative. J5A is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

J5A had negative earnings in the past year.
In the past year J5A had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: J5A reported negative net income in multiple years.
J5A had a positive operating cash flow in each of the past 5 years.
J5A.DE Yearly Net Income VS EBIT VS OCF VS FCFJ5A.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B -10B

1.2 Ratios

The Return On Assets of J5A (-10.82%) is worse than 74.42% of its industry peers.
Looking at the Return On Equity, with a value of -33.23%, J5A is doing worse than 72.09% of the companies in the same industry.
J5A has a Return On Invested Capital (0.46%) which is in line with its industry peers.
Industry RankSector Rank
ROA -10.82%
ROE -33.23%
ROIC 0.46%
ROA(3y)-6.3%
ROA(5y)-2.79%
ROE(3y)-18.63%
ROE(5y)-8.08%
ROIC(3y)N/A
ROIC(5y)N/A
J5A.DE Yearly ROA, ROE, ROICJ5A.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

J5A has a Operating Margin (1.46%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of J5A has declined.
The Gross Margin of J5A (43.00%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of J5A has declined.
Industry RankSector Rank
OM 1.46%
PM (TTM) N/A
GM 43%
OM growth 3Y-55.14%
OM growth 5Y-45.05%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.55%
GM growth 5Y-8.3%
J5A.DE Yearly Profit, Operating, Gross MarginsJ5A.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), J5A is destroying value.
The number of shares outstanding for J5A has been increased compared to 1 year ago.
J5A has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, J5A has a worse debt to assets ratio.
J5A.DE Yearly Shares OutstandingJ5A.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
J5A.DE Yearly Total Debt VS Total AssetsJ5A.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

Based on the Altman-Z score of 0.39, we must say that J5A is in the distress zone and has some risk of bankruptcy.
J5A's Altman-Z score of 0.39 is on the low side compared to the rest of the industry. J5A is outperformed by 72.09% of its industry peers.
J5A has a debt to FCF ratio of 9.03. This is a negative value and a sign of low solvency as J5A would need 9.03 years to pay back of all of its debts.
J5A has a Debt to FCF ratio (9.03) which is in line with its industry peers.
A Debt/Equity ratio of 1.09 is on the high side and indicates that J5A has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.09, J5A is doing worse than 60.47% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.09
Debt/FCF 9.03
Altman-Z 0.39
ROIC/WACC0.07
WACC6.75%
J5A.DE Yearly LT Debt VS Equity VS FCFJ5A.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

J5A has a Current Ratio of 0.89. This is a bad value and indicates that J5A is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.89, J5A perfoms like the industry average, outperforming 51.16% of the companies in the same industry.
A Quick Ratio of 0.89 indicates that J5A may have some problems paying its short term obligations.
With a Quick ratio value of 0.89, J5A perfoms like the industry average, outperforming 53.49% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.89
Quick Ratio 0.89
J5A.DE Yearly Current Assets VS Current LiabilitesJ5A.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 27.78% over the past year.
J5A shows a decrease in Revenue. In the last year, the revenue decreased by -4.84%.
J5A shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 28.68% yearly.
EPS 1Y (TTM)27.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-25%
Revenue 1Y (TTM)-4.84%
Revenue growth 3Y47.75%
Revenue growth 5Y28.68%
Sales Q2Q%-2.5%

3.2 Future

The Earnings Per Share is expected to grow by 23.44% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 0.69% on average over the next years.
EPS Next Y75.22%
EPS Next 2Y44.43%
EPS Next 3Y28.92%
EPS Next 5Y23.44%
Revenue Next Year-1.67%
Revenue Next 2Y-0.48%
Revenue Next 3Y0.38%
Revenue Next 5Y0.69%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
J5A.DE Yearly Revenue VS EstimatesJ5A.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B 40B 50B
J5A.DE Yearly EPS VS EstimatesJ5A.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 -4

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for J5A. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for J5A. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
J5A.DE Price Earnings VS Forward Price EarningsJ5A.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, J5A is valued cheaply inside the industry as 86.05% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, J5A is valued cheaply inside the industry as 83.72% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 4.78
EV/EBITDA 2.66
J5A.DE Per share dataJ5A.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10 -15

4.3 Compensation for Growth

A more expensive valuation may be justified as J5A's earnings are expected to grow with 28.92% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y44.43%
EPS Next 3Y28.92%

0

5. Dividend

5.1 Amount

J5A does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

WARNER BROS DISCOVERY INC

FRA:J5A (5/2/2025, 7:00:00 PM)

7.572

-0.05 (-0.72%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)02-27 2025-02-27/bmo
Earnings (Next)05-08 2025-05-08/bmo
Inst Owners68.22%
Inst Owner ChangeN/A
Ins Owners1.05%
Ins Owner ChangeN/A
Market Cap18.73B
Analysts72.73
Price Target11.6 (53.2%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-658.23%
Min EPS beat(2)-1474.18%
Max EPS beat(2)157.73%
EPS beat(4)1
Avg EPS beat(4)-360.29%
Min EPS beat(4)-1474.18%
Max EPS beat(4)157.73%
EPS beat(8)1
Avg EPS beat(8)-1374.61%
EPS beat(12)3
Avg EPS beat(12)-525.58%
EPS beat(16)4
Avg EPS beat(16)-403.48%
Revenue beat(2)0
Avg Revenue beat(2)-2.68%
Min Revenue beat(2)-2.77%
Max Revenue beat(2)-2.58%
Revenue beat(4)0
Avg Revenue beat(4)-3.37%
Min Revenue beat(4)-4.51%
Max Revenue beat(4)-2.58%
Revenue beat(8)0
Avg Revenue beat(8)-2.44%
Revenue beat(12)0
Avg Revenue beat(12)-8.68%
Revenue beat(16)2
Avg Revenue beat(16)-6.41%
PT rev (1m)-8.49%
PT rev (3m)-2.29%
EPS NQ rev (1m)-10.64%
EPS NQ rev (3m)-53.66%
EPS NY rev (1m)-9.82%
EPS NY rev (3m)-70.13%
Revenue NQ rev (1m)-1.02%
Revenue NQ rev (3m)-3.91%
Revenue NY rev (1m)-0.29%
Revenue NY rev (3m)-2.22%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.54
P/FCF 4.78
P/OCF 3.93
P/B 0.62
P/tB N/A
EV/EBITDA 2.66
EPS(TTM)-0.8
EYN/A
EPS(NY)-0.2
Fwd EYN/A
FCF(TTM)1.59
FCFY20.94%
OCF(TTM)1.93
OCFY25.43%
SpS14.08
BVpS12.19
TBVpS-15.41
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.82%
ROE -33.23%
ROCE 0.65%
ROIC 0.46%
ROICexc 0.49%
ROICexgc 6.37%
OM 1.46%
PM (TTM) N/A
GM 43%
FCFM 11.26%
ROA(3y)-6.3%
ROA(5y)-2.79%
ROE(3y)-18.63%
ROE(5y)-8.08%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-43.23%
ROICexcg growth 5Y-35.25%
ROICexc growth 3Y-54.46%
ROICexc growth 5Y-42.78%
OM growth 3Y-55.14%
OM growth 5Y-45.05%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.55%
GM growth 5Y-8.3%
F-Score4
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 1.09
Debt/FCF 9.03
Debt/EBITDA 1.77
Cap/Depr 4.64%
Cap/Sales 2.41%
Interest Coverage 0.29
Cash Conversion 25.59%
Profit Quality N/A
Current Ratio 0.89
Quick Ratio 0.89
Altman-Z 0.39
F-Score4
WACC6.75%
ROIC/WACC0.07
Cap/Depr(3y)4.94%
Cap/Depr(5y)6.3%
Cap/Sales(3y)2.84%
Cap/Sales(5y)3.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-25%
EPS Next Y75.22%
EPS Next 2Y44.43%
EPS Next 3Y28.92%
EPS Next 5Y23.44%
Revenue 1Y (TTM)-4.84%
Revenue growth 3Y47.75%
Revenue growth 5Y28.68%
Sales Q2Q%-2.5%
Revenue Next Year-1.67%
Revenue Next 2Y-0.48%
Revenue Next 3Y0.38%
Revenue Next 5Y0.69%
EBIT growth 1Y202.86%
EBIT growth 3Y-33.72%
EBIT growth 5Y-29.28%
EBIT Next Year204.29%
EBIT Next 3Y45.48%
EBIT Next 5Y26.07%
FCF growth 1Y-28.14%
FCF growth 3Y22.22%
FCF growth 5Y7.32%
OCF growth 1Y-28.11%
OCF growth 3Y24.31%
OCF growth 5Y9.6%